Home » Topics » BioWorld Science

BioWorld Science
RSS

BTG-2403: representative opioid analgesic

July 19, 1996

Glaxo Wellcome's Ultiva receives FDA approval

July 19, 1996

RWJ-26819: Non-steroidal progestin agonist from R.W. Johnson

July 12, 1996

U.K. and Canadian approval sought for Alora

July 12, 1996

New formulation of rhGH from Alkermes and Genentech

July 12, 1996

KGR-1380: A novel glycation inhibitor

July 12, 1996

Aldose reductase inhibitors described by Grelan

July 12, 1996

Clinical trials begin for chronic hepatitis C agent, Alferon N Injection

July 12, 1996

Lamivudine for treatment of hepatitis B covered under U.S. patent

July 12, 1996

Otsuka peptide IL-1 production inhibitors in pipeline

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...